Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
Supplied for qualified laboratory research only
While clinical validation of this mechanistic advantage continues to evolve, the dual-inhibition profile positions Polmacoxib as a promising therapeutic option for managing osteoarthritis
doi:10.3389/fendo.2022.1043789 109
Jimmy made allowances for his symptoms at first, chalking them up to the physical demands of his job
Author: Palmetto Peptides Research Team Last Updated: March 30, 2026 Research-grade IGF-1 LR3 is available from Palmetto Peptides
In a 23-week randomized clinical trial in humans, individuals taking AOD-9604 at 1 mg daily had an average of 2.8 kg weight reduction compared to a 0.8 kg weight reduction in those taking a placebo
US$ 29.57
US$ 22.97
US$ 24.15
US$ 22.90
